Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study. - Kovács J; Köllő Z; Karvaly BG; Obeidat M; Nagy R; Hegyi P; Teutsch B; Tuboly E; Garami M (Pediatric blood & cancer, 2026)